DERMATOP® Ointment (prednicarbate ointment) 0.1% contains the non-halogenated prednisolone derivative prednicarbate. The topical corticosteroids constitute a class of primarily synthetic steroids used topically as anti-inflammatory and anti-pruritic agents. Each gram of DERMATOP Ointment 0.1% contains 1.0mg of prednicarbate in a base consisting of white petrolatum, octyldodecanol, glyceryl oleate, propylene glycol, citric acid, and propyl gallate.
DERMATOP Ointment 0.1% is a medium potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.
Media Articles Related to Dermatop ( Topical)
FDA Approves 1st Topical Gel to Ease Redness of Rosacea
Source: MedicineNet brimonidine Specialty [2013.08.28]
Title: FDA Approves 1st Topical Gel to Ease Redness of Rosacea
Category: Health News
Created: 8/27/2013 12:35:00 PM
Last Editorial Review: 8/28/2013 12:00:00 AM
Burn Risk Seen with Topical Pain Relievers
Source: MedPage Today Product Alert [2012.09.13]
WASHINGTON -- The FDA warned Thursday of the risks of rare but serious chemical burns with certain over-the-counter topical pain relievers, including Bengay, Capzasin, Flexall, Icy Hot, and Mentholatum.
Group Offers Guidelines to Lessen Vaccination Pain
Source: Medscape Pediatrics Headlines [2015.08.28]
Clinicians can shuffle the order of vaccine injections, leverage the calming influence of parents and breast-feeding, and routinely apply topical anesthetic to ease vaccination pain for patients.
Medscape Medical News
IL-2 Combo May Curb Cutaneous Metastatic Melanoma
Source: Medscape Dermatology Headlines [2015.08.25]
A combination of intralesional interleukin (IL)-2, imiquimod, and topical retinoid prompted a complete local response in patients with cutaneous metastatic melanoma, and might improve survival, according to a small retrospective study.
Reuters Health Information
Topical drug leads to complete remission for some patients with rare skin lymphoma
Source: Dermatology News From Medical News Today [2015.08.07]
Researchers reveal how a topical drug called resiquimod led to total remission for some patients with a cutaneous T cell lymphoma - a rare skin lymphoma.
Published Studies Related to Dermatop ( Topical)
Efficacy of Benzocaine 20% Topical Anesthetic Compared to Placebo Prior to
Administration of Local Anesthesia in the Oral Cavity: A Randomized Controlled
The aim of the present study was to compare the effects of a topical anesthetic
to a placebo on pain perception during administration of local anesthesia in 2
regions of the oral cavity. A split-mouth, double-blind, randomized clinical
trial design was used...
Treatment of palmar-plantar erythrodysesthesia (PPE) with topical sildenafil: a
pilot study. 
treatment of PPE... CONCLUSIONS: In this limited, single-center study, topical cream containing 1 %
Topical analgesia treats pain and decreases propofol use during lumbar punctures
in a randomized pediatric leukemia trial. 
CONCLUSIONS: This study demonstrated that the combination of EMLA cream with
Effectiveness of topical curcumin for treatment of mastitis in breastfeeding
women: a randomized, double-blind, placebo-controlled clinical trial. 
inflammation in women suffering from lactational mastitis... CONCLUSION: The results of the current study indicate that topical preparation of
"Coffee plus honey" versus "topical steroid" in the treatment of
chemotherapy-induced oral mucositis: a randomised controlled trial. 
steroid, honey, honey plus coffee) in patients suffering from oral mucositis... CONCLUSION: Oral mucositis can be successfully treated by a combination of honey
Clinical Trials Related to Dermatop ( Topical)
Standardized Time- and Score-oriented Treatment of Moderate and Severe Atopic Dermatitis [Completed]
The study was designed to test the hypothesis whether a standardized, time-and
score-oriented treatment following a strict evidence based algorithm is equally effective to
a standard treatment regimen for moderate to severe atopic dermatitis.
Study Type: Mono-centre study, patients are blinded, physicians are randomized to either
treat study- or controll group
Eligible are patients age 2 years or older with SCORAD >= 20 Duration: 12 Months, study
visits every 4 weeks.
Primary endpoint is Difference between Baseline SCORAD and mean SCORAD under treatment.
Secundary endpoints are quality of life, safety and economic burden in both treatment
Bisphosphonate and Anastrozole Trial - Bone Maintenance Algorithm Assessment [Completed]
The purpose of this study is to evaluate the use of an oral bisphosphonate (alendronate) in
preventing bone loss in postmenopausal women with early breast cancer who are receiving
anastrozole therapy, and to determine how long alendronate treatment is needed.
Fexofenadine in Pruritic Skin Disease [Completed]
European Survey of Non-Variceal Upper Gastro Intestinal Bleeding (NVUGIB) [Completed]
Evaluation of Patient Characteristics and Treatment Approaches to Patients With Bipolar Disorder in Turkey [Completed]
A registry study to identify the patient-diagnosis-treatment characteristic profile of
patients with bipolar disorder in Turkey.